Non-valvular atrial fibrillation (NVAF) should be treated with direct-acting oral anticoagulants (DOAC) based on stroke risk (a CHADS2 ≥ 1) and corrected for risk of bleeding (HAS-BLED). Atrial Fibrillation is associated with thromboembolism, heart failure, and death. Fifteen percent (15%) of strokes are caused by an embolus arising from the left atrium, a pathological manifestation … Continue reading Atrial Fibrillation and Stroke